Member Info for sharehead

While many vendors talk about Europe and Asia as the regions of the world they are expanding into, Latin America is going to quickly become the next go to hot spot. In specific countries like Brazil and others, online video consumption has increased significantly in recent years. Just take a look at some of these recent stats: Video market in Brazil is one of largest worldwide – viewing audience of 43 million people monthly and penetration of 82.2% among internet users (Dec/12);Internet is the #2 in advertising spending;Brazil ranks as the 5th largest internet market globallyBrazilians spent $12.2 billion in online retail sales in 2012 – and will spend over $25 billion by 2017.Brazil will host the two most important sport events, World Cup and Olympics, receiving over $30 billion on investment from the Brazilian government.Local Government will invest $ 9 billion in broadband in the next 4 years.Latin Americans spend 56% more time on social networking sites than the worldwide average.People in Latin America spent $3.62 billions in digital ads in 2012 – 112% increase in just four years.In 2013, Latin America will be #2 in the world in digital ad spend. While not every country in Latin America has a large population capable of getting a 2-3Mbps video stream, many do, and they have huge populations with large Internet penetration rates: Argentina: As of March 2010 the country had a 64% Internet penetration rate with 26.6M users with an average broadband speed of 3.33Mbps.Brazil: As of Dec. 2009 the country had a 37.8% Internet penetration rate with 75M users with an average broadband speed of 4.46Mbps.Chile: At the end of 2009 the country had a 50% Internet penetration rate with 10M users with an average broadband speed of 6.62Mbps.Colombia: In mid 2010 the country had a 48% Internet penetration rate with 21M users with an average broadband speed of 4.32Mbps.Mexico: In 2010 the country had a 27% Internet penetration rate with 30.6M users with an average broadband speed of 3.54Mbps.Peru: As of June 2010 the country had a 27% Internet penetration rate with 8.8M users with an average broadband speed of 4.62Mbps. For all of Latin America combined, we’re looking at a population of roughly 600M with more than one-third of them online, with a combined average broadband speed of more than 3 Mbps.

Over-the-top content (OTT) refers to delivery of audio, video, and other media over the Internet without a multiple system operator being involved in the control or distribution of the content. The provider may be aware of the contents of the Internet Protocol packets but is not responsible for, nor able to control, the viewing abilities, copyrights, and/or other redistribution of the content. This is in contrast to purchase or rental of video or audio content from an Internet service provider (ISP), such as pay television video on demand or an IPTV video service, like AT&T U-Verse. OTT in particular refers to content that arrives from a third party, such as Dramatize, Drama fever, Crackle, Hulu, myTV, NetD,Netflix, NowTV, RPI TV, WhereverTV, or WWE Network, and is delivered to an end user device, leaving the ISP responsible only for transporting IP packets........ OTT (Over the Top Technology) and IPTV (Internet Protocol Television) are two growing technology mediums in the media distribution industry that are in place in the market, yet not being used to their full capacity by advertisers or the critical mass.......... Although IPTV is currently more widespread than OTT, tech analysts speculate OTT to take over IPTV in a few years time. This has already happened in the UK.

Market Overview The landscape for digital television in Latin America is changing fast. With the majority of regions including Brazil, Argentina, Peru, Chile and Venezuela preparing for the digital switchover, Latin America could leapfrog more developed digital TV markets despite being late to the party. Unlike many European telecoms providers that are hampered by legacy technologies in the field, Latin American telecom providers and device manufacturers could be in a position to offer more advanced over-the-top services that make use of broadcast and IP domains, from the start. By starting from green fields, Latin America will benefit from a less disparate and confused television environment as telecom operators, manufacturers and media content providers can work together from the beginning to form the industry.

During the year we were pleased to welcome a number of new institutional shareholders to the Group, which we consider a significant demonstration of support for our strategy.

Just tried a dummy BUY and was 12.35p so prev trade a buy, could be that was a tick up from 12.25p some could also have been BUYS, contract news soon.

From RNSs.... We have now entered a new stage in which major players are showing an increased interest in our capabilities. The Company is an advanced negotiations with other potential customers, and we expect to announce new deals after the summer break. References are key in this market and we are now winning really important ones." This has been a transformational period for the Group, in which we have proven our ability to deliver on top-level deals. Despite dedicating significant resources to the trial that led to this flagship contract win, we generated an operating profit for the year, recorded an increase in our adjusted EBITDA Certainly all the ingredients are all there for it to be.

Wonder how big the contracts being negotiated are. Anyone know what the eps is once the tier 1 contract has been factored in, must be low, I see share profits did an article stating a 30p target off the back of this contract, so if more do follow I wonder what the new target would be?

Todays results show a swing into profit even before the tier 1 contract revenues kick in, of which 90 odd % is profit I think, the placing has strengthened the balance sheet to deliver on this and negotiate other contracts, which we are now told are in advanced stages with news due. Last time contract win was announced this went from 10p to 18p. With the money raised and profits coming in in H2 there should be nothing to pull it back this time. Wonder when their summer break ends, mine ends tomorrow!

They have already secured the tier 1 contract and are using that as a point of reference to secure others, as announced today they are hoping to announce further contracts at the end of their summer break, which I guess could be quite soon. This was the announcement for the tier 1 win. mirada plc, the AIM-quoted audio-visual interaction specialist (AIM: MIRA), is delighted to announce that it has secured a major contract for its multiscreen product, iris, with a large established Latin American digital TV operator. This contract follows the successful USD $1.4 million trial previously announced on 7 November 2013. The Company expects the customer to start the commercial roll out before the end of 2014. The contract is expected to generate significant revenues, starting in the second half of the financial year, which the Directors believe should far exceed mirada's yearly turnover over the next three to five years. The customer has an installed subscriber base of several million users, which will be targeted as mirada aims to grow its subscriber-based licence fees. The Directors believe that winning this multi-million dollar contract will further strengthen mirada's reputation in the industry, particularly in South America, and serve a as reference point for discussions with other broadcasters and operators.

We have now entered a new stage in which major players are showing an increased interest in our capabilities. The Company is an advanced negotiations with other potential customers, and we expect to announce new deals after the summer break. References are key in this market and we are now winning really important ones." The tier one contract earnings start to feed in from H2 I believe. Interesting.

Still watching from sidelines. Nearly bought in today, was going to sell some coms but then coms rose so didnt. Looking at the 3 month chart on the 9 day moving average any rise tomorow will break this through the top band, which could then see a sustained rise. If this was sold down to the placing price by the exiting ii's then it makes sense that the new ii buys as per the last 3 rns' s and the cash flow due in from the tier one contract win could take this back up again. Need to read results rns and if good get in I think. Just what to sell ?

Thats 3 rns' s in 2 days with some serious sized buys going on. I see results are out on the 12th, are they loading up pre-results because they expect this to fly? Oh I wish I had spare cash to throw in here. Given the contract won and the small nr of shares could be one to watch.. decisions, decisions.

Not in here but noticed rns 2 days on the trot about large II buys. Was talk of this hitting 20p not long ago, also see results out very soon and they have landed first tier one contract as well. Will keep an eye out and hope it doesn't shoot up before I get some funds come free!! Prob will knowing my Luck.

Share Prophets think this could smash through the 20p's in the near term & if they won a few more big contracts well....... £££££££££££

At the current share price the capitalisation is now just c£13 million. As such the shares trade on a march 2016 PE of just over 4. But if another big contract is won that falls to just over two. For a growth stock which now has cracking revenue visibility that is a joke. We’d be a buyer with a very short term price target of 24p but that now looks conservative - See more at: http://www.shareprophets.advfn.com/views/6007/mirada-we-are-well-ahead-on-this-share-tip-but-still-cheap-at-a-1525p-offer#sthash.EOuyWSuZ.dpuf

Given the massive potential & low nr of shares this could really move fast. Share Prophets believe 24p + near term is being conservative and another big contract would mean a MUCH higher SP target.

Don't forget this is only the 1st of a range of products & also trials with NHS going well. This could now be the start of a serious re-rate. We only dropped from the 30's as the US launch news was delayed so would like to think we can now pass prev highs..... •DermaPure™ targets $1.4 billion a year market for skin substitutes.... •Distribution network now covers 80% of country... •Federal institution distributor appointed..... Tissue Regenix Group plc (AIM: TRX) ("Tissue Regenix" or "the Group"), the regenerative medical devices company, today announces that it has launched DermaPure™ ("DermaPure") its decellularised dermis product in the US. Tissue Regenix's partner CTS (Community Tissue Services) will begin shipping product to customers next week....... In addition to the launch of DermaPure™, the Group also announces that it has continued to expand its distribution network around the country and currently has a network of over 60 reps that covers 80% of the US. Through this network, sale representatives will actively promote Tissue Regenix's dCELL® human dermis in acute care hospitals, Veteran Affairs (VA) Hospitals and institutions, as well as in Long Term Acute Care hospitals (LTACs). ......

This went up into the 30's recently on anticipation of this news & dropped back as the announcement delayed, I expect a steady rise up now. GLA. Tissue Regenix Group plc (AIM: TRX) ("Tissue Regenix" or "the Group"), the regenerative medical devices company, today announces that it has launched DermaPure™ ("DermaPure") its decellularised dermis product in the US. Tissue Regenix's partner CTS (Community Tissue Services) will begin shipping product to customers next week......... In addition to the launch of DermaPure™, the Group also announces that it has continued to expand its distribution network around the country and currently has a network of over 60 reps that covers 80% of the US. Through this network, sale representatives will actively promote Tissue Regenix's dCELL® human dermis in acute care hospitals, Veteran Affairs (VA) Hospitals and institutions, as well as in Long Term Acute Care hospitals (LTACs). ....... Furthermore, Tissue Regenix has also signed an exclusive government supplier partnership with TASSMA for the distribution of DermaPure™. TASSMA provides business development services to medical device and equipment manufacturers seeking to rapidly grow their federal government market share. The partnership with TASSMA will allow Tissue Regenix to immediately target the Department of Veteran's Affairs Healthcare System and the numerous branches of the US military......... The commercial launch of the DermaPure™ dermis allograft will now allow Tissue Regenix to target a market worth $1.4bn a year for wound healing devices and equipment. 6.5 million US patients are afflicted by chronic wounds currently.........

TRX looks to have solved some well defined shortcomings in tissue engineering, added the broker. “Essentially [it is] a materials play in this exciting new field” and ultimately Panmure believes a bid will be made for the company. “Looking at near neighbour’s Tissue Science Laboratory trade sale and Advanced BioHealing, we conclude Tissue Regenix will also likely be a trade sale. In house broker’s Jefferies have an estimate of a possible take-out value of more than US$1.5bn if all of the product areas hit home runs. The message seems clear enough – this is one to watch both for rivals and investors. Commercial US launch due any time.

Tissue Regenix – This business has developed a technology called dCELL which encourages cell growth via a scaffolding patch which is inserted into the designated area and attracts the body’s own cells to the wound area thus enabling the body to regenerate and repair itself without the need for further invasive activity. The technology can also be applied to heart valve replacement procedures where the new valve – sourced from pigs – is ‘stripped down’ by the dCELL technology and inserted into the patient. The new valve then undergoes a regenerative process using the patient’s own cells thus lowering the likelihood of rejection and infection. The global tissue heart valve market is worth $1.0bn+ so the potential is very big indeed. The interesting feature about the wound application is that it does not require a series of lengthy trials, submissions and approvals. As such, the company has already secured US distribution agreements for what will be known as DermaPure, entering into a market worth $1.4bn. The share priced did rise significantly on the back of the US deal – from 15p to 24p – but there is plenty more in the tank once revenues start to filter through from the US deals. Equally, we expect the NHS to adopt the dCELL wound product by the end of 2014 as a result of what appear to be already successful outcomes so far in current trial situations. If we had a banker bet for 2014, then this would be it.